|
TJP2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.574400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.785200E-01 |
| Normal-vs-Stage2 |
1.993990E-01 |
| Normal-vs-Stage3 |
6.386800E-01 |
| Normal-vs-Stage4 |
1.235000E-01 |
| Stage1-vs-Stage2 |
7.325800E-02 |
| Stage1-vs-Stage3 |
3.355200E-01 |
| Stage1-vs-Stage4 |
3.292300E-02 |
| Stage2-vs-Stage3 |
2.996200E-01 |
| Stage2-vs-Stage4 |
9.481600E-01 |
| Stage3-vs-Stage4 |
2.739000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.519600E-01 |
| Normal-vs-AfricanAmerican |
7.835800E-01 |
| Normal-vs-Asian |
5.306400E-01 |
| Caucasian-vs-AfricanAmerican |
8.426600E-01 |
| Caucasian-vs-Asian |
5.934600E-01 |
| AfricanAmerican-vs-Asian |
8.623600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.800190E-01 |
| Normal-vs-Female |
8.418200E-01 |
| Male-vs-Female |
4.482300E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.375800E-01 |
| Normal-vs-Age(41-60Yrs) |
9.746200E-01 |
| Normal-vs-Age(61-80Yrs) |
1.036400E-02 |
| Normal-vs-Age(81-100Yrs) |
3.437500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.445390E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.045120E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.779000E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.139600E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.396140E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.783380E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.232400E-01 |
| Classical-VS-Follicular |
3.53772566796806E-12 |
| Classical-VS-Other |
5.685000E-01 |
| Classical-VS-Normal |
1.479440E-01 |
| Tall-VS-Follicular |
4.048000E-04 |
| Tall-VS-Other |
9.159800E-01 |
| Tall-VS-Normal |
9.981600E-01 |
| Follicular-VS-Other |
7.097900E-02 |
| Follicular-VS-Normal |
2.38160000000098E-05 |
| Other-VS-Normal |
9.118400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.295200E-01 |
| Normal-vs-N1 |
7.484800E-01 |
| N0-vs-N1 |
5.705800E-01 |
|
|
